Ongoing research aims to develop new HER2-targeted therapies and improve existing ones. Scientists are exploring combination therapies, immune checkpoint inhibitors, and personalized medicine approaches to enhance the effectiveness of treatments. Additionally, research is being conducted on overcoming resistance to current therapies, which remains a significant challenge.
